Adicet Bio Inc (ACET)
1.76
-0.05
(-2.76%)
USD |
NASDAQ |
Apr 26, 10:43
Adicet Bio Free Cash Flow: -98.18M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -98.18M |
| September 30, 2023 | -99.89M |
| June 30, 2023 | -97.88M |
| March 31, 2023 | -89.03M |
| December 31, 2022 | -61.55M |
| September 30, 2022 | -52.74M |
| June 30, 2022 | -49.46M |
| Date | Value |
|---|---|
| March 31, 2022 | -46.82M |
| December 31, 2021 | -64.10M |
| September 30, 2021 | -61.28M |
| June 30, 2021 | -52.49M |
| March 31, 2021 | -49.70M |
| December 31, 2020 | -42.54M |
Free Cash Flow Range, Past 5 Years
-99.89M
Minimum
Sep 2023
-42.54M
Maximum
Dec 2020
-66.59M
Average
-61.28M
Median
Sep 2021
Free Cash Flow Benchmarks
| Sagimet Biosciences Inc | -23.77M |
| Catalyst Pharmaceuticals Inc | 61.86M |
| Codexis Inc | -57.06M |
| Annexon Inc | -121.34M |
| Inhibrx Inc | -197.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.49M |
| Cash from Investing (Quarterly) | -0.136M |
| Cash from Financing (Quarterly) | 0.076M |
| Free Cash Flow Per Share (Quarterly) | -0.5473 |
| Free Cash Flow Yield | -129.7% |